Steris (STE)
Healthcare · NYSE · US
Price as at 1 Oct 2026, 01:57 UTC. Quotes are delayed.
Fundamentals
Valuation and ratings
Steris trades at $210.01, which is 45% below the $305.31 our fair value estimate puts on the business. On that measure alone it screens as undervalued, though a valuation model is an argument rather than a measurement, and the market is frequently right about why something is cheap.
Our moat model scores it 58 out of 100, which is a moat, but not a deep one. A moat is a structural reason competitors cannot take the profits away, and it matters more to a long holding period than any single quarter's numbers do.
It changes hands at 27.2 times earnings. Be careful reading that in isolation: for a cyclical business a low P/E arrives at the top of the cycle, when profits are peaking and about to fall, which is exactly when the shares look cheapest and are not.
STE dividend history
Dividends per share by year
| Year | Total per share | Payments |
|---|---|---|
| 2026 (year to date) | $1.95 | 3 |
| 2025 | $1.77 | 3 |
| 2024 | $2.18 | 4 |
| 2023 | $1.98 | 4 |
| 2022 | $1.80 | 4 |
| 2021 | $1.66 | 4 |
| 2020 | $1.54 | 4 |
| 2019 | $1.42 | 4 |
| 2018 | $1.30 | 4 |
| 2017 | $1.18 | 4 |
| 2016 | $1.06 | 4 |
Split-adjusted amounts in the listing currency, grouped by the calendar year of the ex-dividend date, from the filed record. Growth and streak figures compare complete years only.
STE earnings and analyst estimates
Recommendation mix, 8 published ratings
Estimates are the published analyst consensus and move often. An earnings date is scheduled, not certain, and a share tends to reprice most violently on the day itself.
About Steris
STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The company offers cleaning chemistries and sterility assurance products, automated endoscope reprocessing system and tracking products, endoscopy accessories, instruments, washers, and sterilizers and other pieces of capital equipment, as well as equipment used directly in the procedure rooms, including surgical tables, lights, equipment management services, and connectivity solutions; and various preventive maintenance programs, repair services, custom process improvement consulting, and outsourced instrument sterile processing, as well as instrument, devices, and endoscope repair and maintenance services. It also provides process controls and monitoring systems, as well as integrated sterilization equipment, such as accelerators, product handling, and automation; and sterilization modalities, product development, materials testing, and process validation, as well as support services for sterilization equipment and control systems comprising installation, preventive maintenance, updates, repairs, and troubleshooting. In addition, the company offers pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators; and preventive maintenance programs and repair services to support the operation of capital equipment. It serves healthcare providers, medical device and pharmaceutical manufacturers, biopharmaceutical manufacturing facilities, and hospitals. The company was formerly known as New STERIS Limited and changed its name to STERIS plc in November 2015. STERIS plc was founded in 1985 and is headquartered in Mentor, Ohio.
Company profile, industry and headcount are as reported by our data provider and can lag a company's own filings by a reporting period. The annual report is the authority.
STE passes 3 of our 30 screens today
Each screen prints the exact criteria it used, and the circumstances in which it is wrong.
Politician trades in STE
We hold 22 disclosed trades in STE by members of Congress and executive-branch officials. The latest 5:
- Kevin Hern · HouseSell · $15,001 - $50,000 · traded 15 Sept 2026 · disclosed 25 Sept 2026
- April McClain Delaney · HouseSell · $100,001 - $250,000 · traded 25 Aug 2026 · disclosed 9 Sept 2026
- April McClain Delaney · HouseSell · $1,001 - $15,000 · traded 31 Jul 2026 · disclosed 3 Aug 2026
- April McClain Delaney · HouseSell · $1,001 - $15,000 · traded 29 Jul 2026 · disclosed 3 Aug 2026
- April McClain Delaney · HouseSell · $1,001 - $15,000 · traded 27 Jul 2026 · disclosed 3 Aug 2026
A disclosure reports a value band, not an amount, and is due up to 45 days after the trade; some arrive later. Every filer we track, each with their own page, is on the Congress trading tracker.
STE peers
The largest companies in the same industry, then in the same sector.
- NOVO-B.CO Novo Nordisk
- LLY Eli Lilly and Company
- JNJ Johnson & Johnson
- ABBV AbbVie Inc.
- MRK Merck & Co., Inc.
- UNH UnitedHealth Group Incorporated
- NVSEF Novartis AG
- AZN AstraZeneca (ADR)
Every healthcare company we cover is on the Healthcare hub.
Common questions
Is Steris (STE) undervalued?
Against our fair value estimate of $305.31, STE at $210.01 is 45% below fair value. That is one model's answer, not a recommendation. It is built from normalized earning power with growth capped deliberately low, which understates companies whose value is mostly future growth.
What is STE's P/E ratio?
STE trades at 27.2 times earnings. A low P/E is not automatically cheap: on a cyclical company it is usually a warning that earnings are at a peak.
Does Steris (STE) pay a dividend?
Yes. Steris yields 1.17% at the current share price. It has paid $1.95 per share over the trailing twelve months. It has paid a dividend in each of the last 21 complete calendar years. A dividend is declared by the board and can be cut at any time; a yield is a fact about the current price, not a promise.
Where does SteadyShares get its STE data?
Fundamentals for STE come from company filings and exchange data, as listed on NYSE; institutional ownership comes from SEC 13F filings. The share price shown was last refreshed on 1 Oct 2026, 01:57 UTC and is delayed. Metrics we do not hold are left out of the page rather than estimated.
The full research page for STE, with financial statements, ownership detail, peer comparison and alerts, is free inside the app.
Data from company filings, exchange quotes and SEC EDGAR 13F disclosures. Quotes are delayed. Metrics we do not have are left out rather than estimated. Educational information, not financial advice.